François Berthézène
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 14
- Thyroid Disorders and Treatments 5
- Pituitary Gland Disorders and Treatments 4
- Growth Hormone and Insulin-like Growth Factors 3
- Clinical Biochemistry top 2%
- Nephrology top 5%
-
- Lipid metabolism and disorders 5
- Cardiac Health and Mental Health 2
- Biochemistry top 10%
-
- Lipoproteins and Cardiovascular Health 7
- Cholesterol and Lipid Metabolism 5
- Co-authors
- Philippe MoulinFabrice BonnetPatrice NonyJean‐Louis TerraKate IrvingGabriel PonsinAgnès SassolasSophie Bernard
- Journals
- New England Journal of Medicine (1 paper)The Journal of Clinical Endocrinology & Metabolism (6 papers)Diabetes Care (1 paper)
- Partner nations
- FranceUnited StatesNetherlands
In The Last Decade
François Berthézène
34 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 114
- Endocrinology, Diabetes and Metabolism 540
- Clinical Biochemistry 189
- Nephrology 194
- Cardiology and Cardiovascular Medicine 472
- Biochemistry 63
Countries citing papers authored by François Berthézène
This map shows the geographic impact of François Berthézène's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Berthézène with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Berthézène more than expected).
Fields of papers citing papers by François Berthézène
This network shows the impact of papers produced by François Berthézène. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Berthézène. The network helps show where François Berthézène may publish in the future.
Co-authorship network
The 25 scholars most cited alongside François Berthézène, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 4 | |
| 2 | 2005 | 64 | |
| 3 | 2004 | 5 | |
| 4 | 2004 | 330 | |
| 5 | 2004 | 30 | |
| 6 | Le traitement par GH et les conséquences métaboliques et vasculaires du déficit en GH chez l'adulte | 2002 | 0 |
| 7 | 2001 | 23 | |
| 8 | 2001 | 221 | |
| 9 | 1999 | 39 | |
| 10 | 1998 | 40 | |
| 11 | 1998 | 52 | |
| 12 | 1994 | 11 | |
| 13 | 1993 | 45 | |
| 14 | 1989 | 21 | |
| 15 | 1988 | 48 | |
| 16 | 1988 | 5 | |
| 17 | 1987 | 13 | |
| 18 | 1987 | 13 | |
| 19 | 1974 | 2 | |
| 20 | 1973 | 1 |
About François Berthézène
François Berthézène is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry and Clinical Biochemistry, having authored 36 papers that have together received 1.6k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers), Lipoproteins and Cardiovascular Health (7 papers), Cholesterol and Lipid Metabolism (5 papers), Lipid metabolism and disorders (5 papers), Thyroid Disorders and Treatments (5 papers), Pituitary Gland Disorders and Treatments (4 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Cardiac Health and Mental Health (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (540 citations), Clinical Biochemistry (189 citations) and Nephrology (194 citations). François Berthézène has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Philippe Moulin, Fabrice Bonnet, Patrice Nony, Jean‐Louis Terra, Kate Irving, Gabriel Ponsin, Agnès Sassolas, Sophie Bernard, Anik Girard-Globa and Huibi Cao. Their work appears in journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.